Product NDC: | 63629-4914 |
Proprietary Name: | Cetirizine Hydrochloride |
Non Proprietary Name: | Cetirizine Hydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Cetirizine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63629-4914 |
Labeler Name: | Bryant Ranch Prepack |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077829 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091001 |
Package NDC: | 63629-4914-1 |
Package Description: | 30 TABLET in 1 BOTTLE (63629-4914-1) |
NDC Code | 63629-4914-1 |
Proprietary Name | Cetirizine Hydrochloride |
Package Description | 30 TABLET in 1 BOTTLE (63629-4914-1) |
Product NDC | 63629-4914 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cetirizine Hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20091001 |
Marketing Category Name | ANDA |
Labeler Name | Bryant Ranch Prepack |
Substance Name | CETIRIZINE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |